Industry | 制造业 | ||||||||||||||||||||||||
Company Introduction | 广州阳普医疗科技股份有限公司是是一家为临床检验实验室与临床护理提供相关技术、产品和服务的高新技术企业.公司主营业务是为临床检验实验室与临床护理提供以专业解决方案为依托的技术、产品和服务.主要产品为第三代真空采血系统.公司2003年成为"全国医用临床检验室和体外诊断系统标准化技术委员会(SAC/TC136)"单位委员,参与行业相关国家标准和行业标准的制定.2005年被广州市科技局认定为"高新技术企业",2008年首批获得国家"高新技术企业"认定.2003年~2006年被评为"广东省医药行业优秀企业";2007年被中国民营企业促进会评为"优秀民营科技企业突出贡献奖";2007年被广东省知识产权局评为"知识产权优势企业"、"广州市进出口优势企业知识产权工作推进计划首批试点企业";2009年VBCT安全环保型真空采血管被评为"广东省重点新产品";2009年环保型自动定量PET塑料真空采血管被认定为"广东省自主创新产品";2009年被广东省对外贸易经济合作厅认定为"2009~2011年度重点培养和发展的广东省出口名牌"。 | ||||||||||||||||||||||||
Main Business | 以为临床实验室诊断与临床护理提供专业解决方案为依托的技术、产品和服务。 | ||||||||||||||||||||||||
Legal Representative | 邓冠华 | ||||||||||||||||||||||||
Top Executives |
|
||||||||||||||||||||||||
Top 5 Shareholder |
|
||||||||||||||||||||||||
Company Secretary | 余威 | ||||||||||||||||||||||||
Solicitors | 广东精诚粤衡律师事务所 | ||||||||||||||||||||||||
Auditors | 立信会计师事务所(特殊普通合伙) | ||||||||||||||||||||||||
Tel No | 020-32218167;020-32312573 | ||||||||||||||||||||||||
Fax No | 020-32312667 | ||||||||||||||||||||||||
Website | www.improve-medical.com | ||||||||||||||||||||||||
board@improve-medical.com;liulu@improve-medical.com | |||||||||||||||||||||||||
Company Address |
|
||||||||||||||||||||||||
Listing Date | 25/12/2009 | ||||||||||||||||||||||||
Shares Capital |
|
||||||||||||||||||||||||
EPS(RMB)* | ¥ -0.200 | ||||||||||||||||||||||||
DPS(RMB)* | -- | ||||||||||||||||||||||||
NBV Per Share(RMB)* | ¥ 2.339 | ||||||||||||||||||||||||
Market Capitalization(RMB) | 1.601B |
Only Chinese content is avaliable | |
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
* | Unadjusted Data |
Information provided by: etnet | ||
Terms and Conditions |
Risk Disclosure: |
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
Disclaimer: |
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |